WinstonWınston
Back
Encision logo

Encision

ECIA
11
Medical - Instruments & Supplies · Healthcare
Price
$0.04
+0.00 (+0.00%)
Market Cap
$505,476
Winston Score
11
Winston is worried
Weak fundamentals across most pillars.
Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Weak
Cash Flow
Weak
Stability
Mixed
Valuation
Data not available

Share count rising — dilution

+28.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 11.6M (2022) → 14.9M (2026)

Winston Score History

The full picture

Encision Inc. makes surgical tools used in operating rooms. The company specializes in electrosurgical instruments — devices that use electrical energy to cut tissue and stop bleeding during surgery. Its main customers are hospitals and surgical centers, and its flagship technology is a safety system called AEM (Active Electrode Monitoring) that reduces the risk of accidental burns to patients during minimally invasive surgery.

Encision sells its products through a combination of hardware sales and a recurring blade and instrument business, meaning hospitals keep buying disposable tools after the initial purchase. The company operates primarily in the United States and is a small player in the broader surgical instruments market, competing against much larger companies like Medtronic and Stryker. Its AEM safety technology is a key differentiator, but the company's negative operating margin signals it is spending more than it earns, and sustaining profitability while competing against well-funded rivals remains the central challenge.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-24.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+140.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$758,960/ year

Rising (+28% vs prior year)

13.1% of revenue

Below sector average (18%)

Investing heavily in future products and technology

Insider Activity

63.3%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~12 months

$170,756 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Adequate runway but may need to raise capital within 2 years

Revenue declining

Encision's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
46.9%
Healthy — 46.9% gross margin
Profit after running costs
Operating Margin
-11.0%
Losing money on operations — -11.0%
Return on the money invested
ROCE
-26.3%
Weak — -26.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-11.8%
Shrinking sales (-11.8% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-7.4%
Burning cash (-7.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.69
Moderate — manageable debt (0.69)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial